Snoring

09/01/2015 - "Application of TCRFTA at the BOT was associated with a significant reduction in RDI (RoM 0.60, CI 0.47-0.76), ESS (RoM 0.59, CI 0.51-0.67), and VAS snoring (RoM 0.48, CI 0.37-0.62) and increase in lowest oxygen saturation (RoM 1.05, CI 1.01-1.10). "
02/01/2008 - "The median minimal oxygen saturation and snoring index scores also improved statistically significantly (P < .001 for both). "
09/01/2003 - "The mean respiratory disturbance index decreased from 41.6 +/- 28.2 to 12.5 +/- 18.1(P <.0001), and the mean minimal oxygen saturation and snoring index improved significantly (P <.0001). "
08/01/2001 - "It was found that the respiratory disturbance index decreased significantly; minimal oxygen saturation increased significantly, reaching a normal value; day time tiredness improved; snoring declined; the oral cavity anterior region increased significantly, and the pharyngeal airway passages did not change. "
03/01/1997 - "Clinically, all patients were improved symptomatically in terms of snoring, noisy breathing, and oxygen requirements. "

04/01/2015 - "Nasal steroids in snorers can decrease snoring frequency: a randomized placebo-controlled crossover trial."
01/01/2010 - "To treat snoring with nasal steroids - effects on more than one level?"
01/01/2015 - "Snoring and/or obstructive apneas were present in some patients, but they were improved by diaphragm pacer changes, adenotonsillectomy, and/or use of nasal steroids. "
04/01/2015 - "Although it is anecdotally known that nasal obstruction is associated with snoring, it remains unknown whether the application of nasal steroids could decrease oral/oro-nasal breathing and increase nasal breathing, and subsequently decrease snoring indices. "
05/01/2013 - "Nasal medications, including intranasal steroids and nasal decongestants, have not been shown to improve either snoring or OSA. "

01/01/2013 - "The present study showed that the treatment with agomelatine has improved the symptoms of NES and mood, decrease of body weight, reduce, albeit not in an optimal manner, the number of awakenings per night with a reduction of movement time and snoring . "
01/01/2013 - "After three months of observation, the use of Agomelatine not only improved the mood of our NES patient (assessed in the HAM-D scores) but it was also able to reduce the night eating questionnaire, by both reducing the number of nocturnal awakenings with food intake, the time of snoring, the minutes of movement during night sleep (assessed at polysomnography), and the weight (-5.5 kg) and optimizing blood glucose and lipid profile. "

06/01/2012 - "Nasal symptoms and snoring significantly improved after nasal douching, and an additional gain was observed when mometasone furoate was included to treatment. "
01/01/2010 - "Use of mometasone furoate (MF) for 3 months reduced snoring and related symptoms in some patients. "
01/01/2015 - "Topical mometasone significantly improved nasal obstruction, snoring, and apnea and also significantly reduced the adenoid tissue area related to the nasopharynx (p < 0.0001). "
10/01/2015 - "Mometasone caused improvements in outcomes of nasal obstruction, snoring, total nasal symptoms, pure tune audiometry, otitis media with effusion, adenoid size, and quality of life. "
10/01/2015 - "After the administration of mometasone, there were significant improvements in grades of nasal obstruction, 0.8±0.5 versus 2.0±0.6, WMD -1.16 [-2.09, -0.23], snoring 0.3±0.4 versus 1.6±0.6, WMD -1.07 [-2.09, -0.05], total nasal symptoms 2.9±1.3 versus 6.9±1.5, WMD -4.09 [-6.64, -1.53], obstructive sleep apnea, 0.6±0.3 versus 1.4±0.4, WMD -0.95 [-1.74, -0.16], as well as the percentage of patients with nasal obstruction, snoring, obstructive sleep apnea, compared to control. "

04/01/2006 - "To assess efficacy of polyethylene terephthalate (PET) implants in the soft palate for the treatment of socially significant snoring. "
06/01/2004 - "To evaluate the safety and efficacy of polyethylene terephthalate implants in the soft palate to modify disturbing snoring. "
06/01/2004 - "Polyethylene terephthalate implants in the soft palate should be further explored as a treatment for snoring."

09/01/2004 - "The bipolar radiofrequency method with the ORL-Set (RaVoR) has proven to be a safe and effective means for the treatment of snoring and some cases of SAS."
04/01/2006 - "SAS symptoms are frequent during pregnancy and snoring appears to be linked with PIH. "
01/01/2000 - "In our country we have applied this method as the first in the treatment of snoring and SAS. "
09/01/1995 - "The most common symptoms of SAS include excessive daytime sleepiness, nocturnal breath cessation, snoring and gasping sounds. "
04/01/1993 - "In the second stage, a group of 97 women highly suspected of SAS were selected because of their habitual snoring and daytime sleepiness. "

12/01/1998 - "Snorers with reduced snoring and morning tiredness due to improved nasal breathing showed an increase in morning IGF-1 concentration which can probably be explained by higher nocturnal GH secretion induced by more deep sleep."
02/01/2009 - "Among snoring children without OSA, circulating IGF-1 was 910 +/- 110 pg/mL compared with 1070 +/- 240 pg/mL in those with OSA (p<0.01). "
11/01/1996 - "Sleep studies (using the MESAM-4 device measuring oxyhaemoglobin saturation, heart rate, snoring sounds and body position to determine presence and severity of sleep apnoea); GH and IGF-I levels; body mass index, neck and index-finger circumference; daytime symptoms of sleep apnoea, duration of acromegaly before treatment, shoe and neck-size difference since beginning of acromegaly; age, sex and treatment modes of acromegaly. "
10/01/2001 - "After treatment, there were significant improvements in hormonal profile: GH, mU/l (before, 51.5 +/- 27.8; after, 8.0 +/- 7.4; P = 0.017) and IGF-1, nmol/l (before, 95.5 +/- 23.4; after, 35.0 +/- 12.4; P = 0.012); sleep-disordered breathing: AHI (before, 29.4 +/- 22.6; after, 13.4 +/- 11.12; P = 0.025), snoring episodes (before, 486 +/- 240; after, 165 +/- 170; P = 0.05); cephalometric indices, mm: MPH (before, 18.8 +/- 12.1; after, 14.8 +/- 8.4; P = 0.018), VT (before, 72.3 +/- 4.4; after, 69.7 +/- 4.3; P = 0.05). "

04/01/2015 - "This study evaluated the effect of nasal budesonide on breathing route pattern and snoring. "
04/01/2015 - "Nasal budesonide in snorers can increase nasal breathing epochs, modestly decrease snoring frequency and increase rapid eye movement sleep. "
04/01/2015 - "Nasal budesonide was associated with a decrease in oral/oro-nasal breathing epochs and concomitant increase in nasal breathing epochs, decrease of snoring frequency by [median (interquartile range)] 15.8% (11.2-18.8%), and an increase of rapid eye movement sleep; snoring intensity decreased only in patients with increased baseline nasal resistance by 10.6% (6.8-14.3%). "
08/01/2004 - "Budesonide 50 mcg per nostril twice daily was administered for 4 weeks to children (2-14 years old) with habitual snoring and an apnea-hypopnea index of 1-10 episodes/hr. Subjects were evaluated before treatment and at 2 weeks and 9 months after its completion. "
07/01/2005 - "Resolution of nocturnal enuresis in snoring children after treatment with nasal budesonide."

01/15/2006 - "At the end of the open-label trial, a subset of subjects whose snoring had recurred were randomized to one or both placebo-controlled trials, either 60 mg of pseudoephedrine sulfate plus 10 mg of domperidone or to 30 mg of pseudoephedrine sulfate plus 10 mg of domperidone. "
01/15/2006 - "Thirty healthy individuals whose sleeping partners reported that the patients had severe nightly snoring entered an open-label trial of 60 mg of pseudoephedrine and 10 mg of domperidone at bedtime for 30 days. "
01/15/2006 - "Treatment of severe snoring with a combination of pseudoephedrine sulfate and domperidone."
04/15/2010 - "The combination of domperidone and pseudoephedrine improved self reported snoring and sleepiness, and may have improved apneic episodes and sleep-related nocturnal oxygen desaturation in patients with obstructive sleep apnea provided the proportion of time spent asleep did not diminish. "

01/15/2006 - "At the end of the open-label trial, a subset of subjects whose snoring had recurred were randomized to one or both placebo-controlled trials, either 60 mg of pseudoephedrine sulfate plus 10 mg of domperidone or to 30 mg of pseudoephedrine sulfate plus 10 mg of domperidone. "
01/15/2006 - "Thirty healthy individuals whose sleeping partners reported that the patients had severe nightly snoring entered an open-label trial of 60 mg of pseudoephedrine and 10 mg of domperidone at bedtime for 30 days. "
01/15/2006 - "Treatment of severe snoring with a combination of pseudoephedrine sulfate and domperidone."
04/15/2010 - "The combination of domperidone and pseudoephedrine improved self reported snoring and sleepiness, and may have improved apneic episodes and sleep-related nocturnal oxygen desaturation in patients with obstructive sleep apnea provided the proportion of time spent asleep did not diminish. "

04/25/2009 - "Are general dental practitioners effective in the management of non-apnoeic snoring using mandibular advancement appliances?"
04/25/2009 - "This study assessed the effectiveness of general dental practitioners (GDPs) in the management of subjects with non-apnoeic snoring using a mandibular advancement appliance (MAA), following a one day training course. "
08/01/2006 - "This randomized, controlled, crossover trial assessed the effectiveness of an adjustable, thermoplastic, mandibular advancement device (MAD), the TheraSnore, in the management of non-apnoeic snoring. "
04/01/2001 - "The aims of this study were to investigate possible orthodontic side-effects following the use of mandibular advancement devices (MAD) in adults with snoring and sleep apnoea. "
02/01/1998 - "Fifteen patients, already established on mandibular advancement devices for the control of snoring, were asked to participate in this study. "

01/01/2001 - "Significant improvement has been reported in subjective measures of snoring after laser-assisted uvulopalatoplasty (LAUP). "
08/01/1999 - "Laser palatoplasty (LPP) is widely used for the treatment of non-apnoeic snoring, despite the lack of objective data supporting its use. "
04/01/1998 - "Laser-assisted uvulopalatoplasty treatment in patients with loud snoring resulted in elimination of snoring in 61%, partial improvement of snoring in 26%, and no improvement in 13%. "
03/01/1996 - "The efficacy of LUPP is compared with various laser procedures for snoring."
08/01/1995 - "Of the 22 patients who had the laser-strip and uvulectomy, snoring improved in 18 (82%) (median improvement of 75% at 3 months). "

04/01/2002 - "The guideline contains the following recommendations for the diagnosis of OSAS: 1) all children should be screened for snoring; 2) complex high-risk patients should be referred to a specialist; 3) patients with cardiorespiratory failure cannot await elective evaluation; 4) diagnostic evaluation is useful in discriminating between primary snoring and OSAS, the gold standard being polysomnography; 5) adenotonsillectomy is the first line of treatment for most children, and continuous positive airway pressure is an option for those who are not candidates for surgery or do not respond to surgery; 6) high-risk patients should be monitored as inpatients postoperatively; 7) patients should be reevaluated postoperatively to determine whether additional treatment is required. "
05/01/2007 - "Continuous positive airway pressure improved sleep quality, although some symptoms, mainly snoring, persisted. "
11/01/2015 - "Although nasal pressure recordings provide information regarding nocturnal breathing abnormalities in a polysomnography (PSG) study or continuous positive airway pressure (CPAP) system, an objective assessment of snoring detection using these nasal pressure recordings has not yet been reported in the literature. "
01/01/2002 - "A bench study using an artificial lung model was performed to evaluate the snoring detection sensitivity of six (commercially available) auto-nasal continuous positive airway pressure (NCPAP) devices. "
10/01/1999 - "Midway through the 1-night study, the patients received nasal continuous positive airway pressure (CPAP) with the pressure adjusted to eliminate snoring and obstructive breathing events. "

03/01/2007 - "A statistically significant reduction of the preoperative snoring levels from 7.5 +/- 2.4 to 6.1 +/- 2.8 was seen after treatment (p < 0.001). "
01/01/2005 - "In simple snoring, the uvula was reduced from 11 to 8.5mm and VAS was relieved from 7 to 2 points after treatment. "
07/01/2006 - "In this study, twenty-three habitual snorers and their bedfellows completed a questionnaire concerning the effect of the treatment of snoring by a Herbst-activator before treatment and 3 and 6 months after treatment. "
01/01/1983 - "The study also examined the relationship between snoring and other sleep parameters, and particularly the occurrence of respiratory obstruction before and after treatment. "
12/01/2014 - "After treatment, Epworth sleepiness scale and snoring severity scores significantly decreased from a mean (SD) of 11.0 (5.0) to 7.8 (2.3) (P = .005) and 6.0 (3.4) to 2.8 (2.3) (P < .001), respectively. "

01/01/2005 - "A greater number of patients achieved complete improvement in snoring in the bilateral tonsillectomy group (p<0.05). "
04/01/2011 - "Five types of surgical treatment for OSA are available, each for its own indications: optimization of the nasal airway to support nasal ventilation therapy, (adeno-)tonsillectomy as first-line treatment for OSA in children, minimally invasive surgery for simple snoring and mild OSA, invasive surgery as first- and second-line treatment for mild OSA, and invasive multilevel surgery as second-line treatment of moderate to severe OSA that remains refractory to ventilation therapy. "
04/01/1998 - "The aim of this study was to determine the relation between snoring and tonsillectomy. "
08/01/2015 - "A total of 53 children who underwent tonsillectomy for either OSAS (n = 25) or primary snoring (PS, n = 28) were prospectively enrolled. "
10/01/2014 - "Effects of adenoid/tonsillectomy on inflammatory response in snoring children with witnessed apnoea."